Anupam Rasayan India Ltd

Thu 27/08/2026,15:59:58 | NSE : ANURAS

₹1259.80-7.80 (-0.62%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1265.50

Previous Close

₹ 1267.60

Volume

136325

Mkt Cap ( ₹ Cr)

₹ 14342.80

High

₹ 1270.00

Low

₹ 1256.00

52 Week High

₹ 1415.00

52 Week Low

₹ 1045.20

Book Value Per Share

₹ 294.52

Dividend Yield

0.11

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Anupam Rasayan India Ltd

Your Vote -

Buy

51.82%

Hold

7.73%

Sell

40.45%

51.82%

220 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Anupam Rasayan India Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Anupam Rasayan India - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Aug 2026, 5:39PM Anupam Rasayan India Limited has informed the Exchange about Transcript of Earnings Call on the Unaudited Financial Results (Standalone and Consolidat
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    20 Aug 2026, 5:28PM Submission of transcript of earnings call on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 3
  • Anupam Rasayan India - Copy of Newspaper Publication

    15 Aug 2026, 5:18PM Anupam Rasayan India Limited has informed the Exchange about submission of newspaper advertisement clippings pertaining to the Unaudited Financial Res
  • Anupam Rasayan India - Analysts/Institutional Investor Meet/Con. Call Updates

    14 Aug 2026, 5:37PM Anupam Rasayan India Limited has informed the Exchange about submission of audio recording on Earnings Call pertaining to Unaudited Financial Results
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    14 Aug 2026, 5:32PM Submission of Audio Recording of Earnings Call pertaining to the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quar
  • Anupam Rasayan India - Investor Presentation

    14 Aug 2026, 12:23PM Anupam Rasayan India Limited has informed the Exchange about Investor Presentation
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Investor Presentation

    14 Aug 2026, 12:21PM Investor Presentation regarding Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
  • Anupam Rasayan India - Press Release

    14 Aug 2026, 12:02PM Anupam Rasayan India Limited has informed the Exchange about a press release dated August 14, 2026, regarding the Unaudited Financial Results (Standal
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    14 Aug 2026, 12:00PM Press Release regarding Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
  • Anupam Rasayan India - Financial Results For The Quarter Ended June 30, 2026.

    14 Aug 2026, 10:11AM The Board of Directors at its meeting held on August 14, 2026 has considered and approved the unaudited financial results (standalone & consolidated)
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Change in Management

    14 Aug 2026, 10:03AM The Board of Directors at its meeting held on August 14, 2026 has considered and approved the appointment of Mr. Ravi Desai as Chief Operating Officer
  • Anupam Rasayan India - Appointment

    14 Aug 2026, 10:02AM Anupam Rasayan India Limited has informed the Exchange regarding Appointment of Mr. Ravi Desai as Chief Operating Officer of the company w.e.f. Augus
  • Anupam Rasayan India - Outcome of Board Meeting

    14 Aug 2026, 9:59AM Anupam Rasayan India Limited has submitted to the Exchange, the Standalone and Consolidated Financial Results for the quarter ended Jun 30, 2026.
  • Anupam Rasayan India - Board Meeting Outcome for Outcome Of Board Meeting Held On August 14, 2026

    14 Aug 2026, 9:58AM The Board of Directors at its meeting held today i.e. August 14, 2026, has inter-alia, considered and approved the Unaudited Financial Results (Standa
  • Anupam Rasayan India - ESOP/ESOS/ESPS

    13 Aug 2026, 7:45PM Anupam Rasayan India Limited has informed the Exchange regarding Allotment of 1531 Equity Shares under ESOP Scheme.
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    13 Aug 2026, 7:38PM Nomination and Remuneration Committee of the Board at its meeting held on August 13, 2026, has approved the allotment of 1531 equity shares under ESOP
  • Anupam Rasayan India - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Aug 2026, 6:35PM Anupam Rasayan India Limited has informed the Exchange about Intimation of the Earnings Call on the Unaudited Financial Results (Standalone and Consol
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    11 Aug 2026, 6:29PM Intimation of the Earnings Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026, scheduled to be
  • Anupam Rasayan India - Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter

    10 Aug 2026, 4:25PM Anupam Rasayan India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider
  • Anupam Rasayan India - Copy of Newspaper Publication

    27 Jul 2026, 6:41PM Anupam Rasayan India Limited has informed the Exchange about submission of newspaper advertisement clippings pertaining to the Pre-Offer Advertisement
  • Anupam Rasayan India - General Updates

    21 Jul 2026, 9:35PM Anupam Rasayan India Limited has informed the Exchange about Letter of Offer regarding the open offer for acquisition of fully paid-up equity shares o
  • Anupam Rasayan India - Announcement Under Regulation 30 (LODR) - Letter Of Offer

    21 Jul 2026, 9:22PM Submission of Letter of Offer regarding the open offer for acquisition of fully paid-up equity shares of Bliss GVS Pharma Limited from the Public Shar
  • Anupam Rasayan India has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Jul 2026, 1:30PM As of June 2026, 59.07% is owned by Promoters and 40.93% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 27.27% and Forei
  • Anupam Rasayan India - Copy of Newspaper Publication

    18 Jul 2026, 7:43PM Anupam Rasayan India Limited has informed the Exchange about Copy of Newspaper Publication pertaining to the Addendum to the Public Announcement, Deta
  • Anupam Rasayan India - General Updates

    17 Jul 2026, 10:40PM Anupam Rasayan India Limited has informed the Exchange about acquisition of shares
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Acquisition

    17 Jul 2026, 10:39PM Acquisition of shares
  • Anupam Rasayan India - Press Release

    15 Jul 2026, 10:48AM Anupam Rasayan India Limited has informed the Exchange regarding a press release dated July 15, 2026, titled ""Anupam Rasayan signs Letter of Intent w
  • Anupam Rasayan signs LOI with BASQUEVOLT for potential $300 million specialty chemicals supply

    15 Jul 2026, 11:03AM Anupam Rasayan India Ltd has signed a non-binding Letter of Intent (LOI) with BASQUEVOLT, S.A., a Spain-based developer of solid-state lithium batteri
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    15 Jul 2026, 10:41AM Press Release Intimation titled \Anupam Rasayan signs Letter of Intent with BASQUEVOLT, S.A. for the potential long-term supply of a specialty chemica
  • Anupam Rasayan India - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Jul 2026, 2:01PM Anupam Rasayan India Limited has informed the Exchange about Confirmation Certificate of Non-Applicablity of Reg. 74(5) of SEBI (DP) Regulations, 2018
  • Anupam Rasayan India - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jul 2026, 1:54PM Confirmation Certificate of Non-Applicability of Reg. 74(5) of SEBI (DP) Regulations.
  • Anupam Rasayan India - Trading Window

    25 Jun 2026, 4:42PM Anupam Rasayan India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulati
  • Anupam Rasayan India - Press Release

    11 Jun 2026, 8:00PM Anupam Rasayan India Limited has informed the Exchange regarding a press release dated Jun 11, 2026, titled Anupam Rasayan India Limited becomes the
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    11 Jun 2026, 7:58PM Intimation of Press Release titled \Anupam Rasayan India Limited becomes the first company in the world to commercialise ETFA (Ethyl trifluoroacetate)
  • Anupam Rasayan India - General Updates

    9 Jun 2026, 7:54PM Anupam Rasayan India Limited has informed the Exchange about Draft Letter of Offer filed by the Manager to the Offer with SEBI yesterday, relating to
  • Anupam Rasayan India - Announcement Under Regulation 30 Of SEBI (LODR) Regulations - Draft Letter Of Offer

    9 Jun 2026, 7:50PM Pursuant to Regulation 30 of the SEBI Listing Regulations, please find attached Draft Letter of Offer filed by the Manager to the Offer with SEBI yest
  • Anupam Rasayan India - Disclosure under SEBI Takeover Regulations

    9 Jun 2026, 12:48PM Kiran Pallavi Investments LLCÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India
  • Anupam Rasayan India - Disclosure under SEBI Takeover Regulations

    9 Jun 2026, 12:46PM Kiran Pallavi Investments LLCÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India
  • Anupam Rasayan India - Disclosure under SEBI Takeover Regulations

    9 Jun 2026, 12:05PM Anand Desaiÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acqui
  • Anupam Rasayan India - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Jun 2026, 6:30PM Anupam Rasayan India Limited has informed the Exchange about Schedule of meet
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Jun 2026, 6:23PM Intimation of schedule of Investor Meet to be held on June 09, 2026
  • Anupam Rasayan India - Credit Rating- Revision

    3 Jun 2026, 9:08PM Anupam Rasayan India Limited has informed the Exchange about Credit Rating- Update by the credit rating agency India Ratings and Research (Ind-Ra)
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Credit Rating

    3 Jun 2026, 9:05PM The credit rating agency, India Ratings and Research (Ind-Ra) has updated the credit rating of the Company
  • Anupam Rasayan India - Credit Rating- Revision

    3 Jun 2026, 1:25PM Anupam Rasayan India Limited has informed the Exchange about Credit Rating- Update by the credit rating agency Crisil Ratings Limited
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Credit Rating

    3 Jun 2026, 1:18PM The credit rating agency CRISIL Ratings Limited has updated credit rating of the Company.
  • Anupam Rasayan India - Copy of Newspaper Publication

    1 Jun 2026, 8:03PM Anupam Rasayan India Limited has informed the Exchange about Copy of Newspaper Publication published pertaining to the Detailed Public Statement for t
  • Anupam Rasayan India - Analysts/Institutional Investor Meet/Con. Call Updates

    30 May 2026, 1:15PM Anupam Rasayan India Limited has informed the Exchange about Transcript
  • Anupam Rasayan India - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    30 May 2026, 1:48PM Submission of Transcript of Earnings Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31.0
  • Anupam Rasayan signs LoI worth $300 m with BASQUEVOLT

    15 Jul 2026 , 11:50AM Anupam Rasayan signs Letter of Intent with BASQUEVOLT, S.A. for the potential long-term supply of a specialty chemical product worth $300 Mn
  • Anupam Rasayan India Ltd

    10 Dec 2025 , 11:44AM Anupam Rasayan: Company has signed a definitive agreement to acquire a 100% equity stake in Jayhawk Fine Chemicals Corporation, a U.S.-based specialty chemical company and part of CABB Group, for a purchase consideration of $150 million. Together, we will leverage our complementary strengths to accelerate growth, enhance our global presence, and deliver greater value to customers across key sectors such as aviation, semiconductors and electronics. Positive
  • Anupam Rasayan inks Master Purchase Agreement with Japanese Multinational Conglomerate

    12 Jun 2025 , 12:35PM Anupam Rasayan inks Master Purchase Agreement with Japanese Multinational Conglomerate, Expanding Strategic Reach in Japan
  • Anupam Rasayan

    11 Mar 2025 , 8:53AM Secured a long term LOI with Korean multinational company for supplying high performance niche chemical. The deal is value at Rs 922 crore. The long term partnership reinforces Anupam's expertise in delivering advanced chemical solutions and strengthens its presence in high-growth global markets. Positive
  • Anupam Rasayan India

    3 Apr 2024 , 10:50AM The company has signed a letter of intent with a Japanese multinational company worth $90 million (Rs 743 crore) over the next 7 years to supply two advanced intermediates using fluorination chemistry. Positive for the Stock
  • Anupam Rasayan India

    26 Dec 2023 , 11:11AM The company has signed Letter of Intent worth Rs 507 crore with Japanese Multi National Chemical company to supply new age polymer intermediate for the next 9 years. Positive
  • Anupam Rasayan signs LoI worth $61 million

    26 Dec 2023 , 10:01AM Anupam Rasayan signs Letter of Intent worth Rs. 507 crore with a leading Japanese MNC
  • Anupam Rasayan signs 3 MoUs with Government of Gujarat

    26 Sep 2023 , 1:26PM Anupam Rasayan signs three MoUs with Government of Gujarat, a collaboration for afforestation
  • Anupam Rasayan Q1 net profit slips by 2.5% YoY

    1 Aug 2023 , 10:37AM Q1 earnings for the Quarter ended June 30, 2023
  • Anupam Rasayan inks MoU with 3xper Innoventure

    4 Jul 2023 , 11:20AM Anupam Rasayan signs Memorandum of Understanding (MoU) with 3xper Innoventure, a technological collaboration for new age pharma molecules
  • Anupam Rasayan

    14 Jun 2023 , 10:24AM The company has signed a Letter of Intent (LoI) worth $265 million (Rs 2,186 crore) with a Japanese speciality chemical company for the supply of new age patented life science active ingredient for next five years. The product will be in validation phase for the next 18 months and upon the successful validation, the supply will commence from CY2025. Positive read through for the stock as the contract is sizable given the company’s FY23 consolidated revenue of Rs1,602 crore.
  • Anupam Rasayan renews long-term contract with German Multinational

    9 May 2023 , 12:22PM Anupam Rasayan renews long-term contract worth Rs. 436 cr with German Multinational for next 3 years
  • Anupam Rasayan signs LoI with Leading American Multinational

    25 Apr 2023 , 10:23AM Anupam Rasayan signs LoI worth Rs. 380 crores with the Leading American Multinational
  • Anupam Rasayan signs LoI worth $182 Million

    13 Apr 2023 , 1:18PM Anupam Rasayan to supply three high value specialty chemicals to a Japanese firm for Rs 1,500 crore
  • Anupam Rasayan

    23 Mar 2023 , 12:03PM Company has signed Letter of Intent worth revenue of $120 Mn (₹984 crores) for next 6 years with one of the leading Japanese Chemical company to supply new age advance intermediate for life science active ingredient. The molecule is based on fluorination chemistry and sales realisation for it will be one of the highest for the company. The product is being manufactured for the first time in India and will be manufactured in company’s existing as well as upcoming multipurpose manufacturing facilities. Positive for the stock
  • Anupam Rasayan signs LoI worth $120 Million

    23 Mar 2023 , 11:47AM Anupam Rasayan signs letter of intent worth $120 m with a Japanese chemical company
  • Anupam Rasayan

    4 Jan 2023 , 12:16PM Anupam Rasayan: Company restarts operations (post receipt of closure revocation order from GPCB) in one plant out of the two plants following the fire accident at the Sachin GIDC Unit. Our view: Positive for the stock
  • Anupam Rasayan signs two Long Term Contracts

    17 Oct 2022 , 11:38AM Anupam Rasayan signs 2 long-term contracts with a European crop protection company
  • Anupam Rasayan India

    29 Sep 2022 , 11:47AM Anupam Rasayan India: The company opened its Rs.500 crore QIP placement issue on September 28 and has fixed floor price of Rs762.88/share and may offer a discount of 5% on floor price. Thus, the indicative issue price of Rs725/share is at a minor discount of 4.4% to CMP of Rs758.
  • Anupam Rasayan India

    26 Sep 2022 , 10:42AM Gujarat Pollution Control Board (GPCB) has issued directions for closure of Anupam Rasayan’s plant in Sachin GIDC as the fire incident at the plant have affected air quality in the nearby area. GPCB has also imposed penalty of Rs1 crore as an interim environmental damage compensation. Negative read through for Anupam Rasayan.
  • Anupam Rasayan

    2 Feb 2022 , 1:58PM Anupam Rasayan: The company’s board of directors has approved to acquire a 24.96% stake in Tanfac Industries Ltd (TIL - Incorporated in 1972, TIL is a specialty fluorides chemical manufacturer) for Rs 148.1 crore from Birla Group Holdings and a few other promoter groups of TIL. Anupam Rasayan will also launch open offer for 26% stake in TIL for Rs154.3 crore (open offer price of Rs595, which is at 12% discount TIL’s CMP of Rs673). TIL posted revenue/EBITDA/PAT of Rs253 crore/Rs65 crore/Rs46 crore in 9MFY22.
  • Anupam Rasayan signs LoI worth Rs 95 mn with multinational crop protection company

    10 Jan 2022 , 1:28PM The company will enter into a long-term contract to supply this life science related speciality chemical product for the next five years
  • Anupam Rasayan signs contract with Japanese Multinational

    15 Dec 2021 , 10:47AM Anupam Rasayan signs Long Term Contract worth Rs. 135 crore with Japanese Multinational Chemical Company
  • Anupam Rasayan signs LOI worth Rs 145 Cr with European Multinational Company

    28 Sep 2021 , 11:40AM Anupam Rasayan will enter into a long-term contract for next three years
  • Anupam Rasayan signs LOI worth Rs. 135 crore

    30 Aug 2021 , 11:29AM Anupam Rasayan signs LOI worth Rs 135 crore with Multinational Chemical Company
  • Anupam Rasayan

    30 Aug 2021 , 11:10AM Anupam Rasayan: The company has received and signed Letter of Intent (LoI) for Rs 135 crore with a Japanese Multinational Chemical company for supplying a life science related speciality chemical product and will enter a long-term contract (for 4 years) to supply product. Positive read through for Anupam Rasayan.
  • Anupam Rasayan to invest Rs. 43 crore for setting up a solar power plant

    4 May 2021 , 11:04AM Anupam Rasayan operates six manufacturing facilities in Gujarat
  • Anupam Rasayan

    28 Apr 2021 , 11:50AM Anupam Rasayan: The company has received and signed letter of intent (LoI) amounting to Rs1100 crore with a MNC Life Sciences Company for supplying life sciences related specialty chemicals for period of five years. Positive read through for Anupam Rasayan.
  • Anupam Rasayan bags order from multinational life sciences company

    28 Apr 2021 , 11:42AM Anupam Rasayan bags Rs. 1,100 cr order from multinational life sciences company

Key fundamentals

Evaluate the intrinsic value of Anupam Rasayan India Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 4758.009 4072.92 3753.034 3147.032 2520.503
Liabilities 4758.009 4072.92 3753.034 3147.032 2520.503
Equity 113.848 109.931 109.786 107.465 100.247
Gross Profit 405.199 265.182 307.009 367.472 296.018
Net Profit 161.396 72.674 117.293 168.529 150.776
Cash From Operating Activities 274.173 -64.822 21.766 243.985 -171.453
NPM(%) 9.63 8.11 10.39 13.12 14.14
Revenue 1675.566 895.899 1128.7 1284.123 1066.001
Expenses 1270.367 630.717 821.691 916.651 769.983
ROE(%) 4.81 2.16 3.49 5.02 4.49

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
1.5 15 0.12 1371.1
21 Jul 2025 0.75 7.5 0.12 1164.2
17 Sep 2024 0.75 7.5 0.12 785.1
20 Nov 2023 0.5 5 0.12 922.65
08 Feb 2023 0.6 6 0.12 596.5
03 Aug 2022 0.4 4 0.12 787.65
02 Sep 2022 1 10 0.12 780.9
17 Nov 2021 0.5 5 0.12 800.65
15 Sep 2021 0.5 5 0.12 757.3

Peers

Other companies within the same industry or sector that are comparable to Anupam Rasayan India Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 1589.50 1.38 13.98 1151.06 1071.07 0.44
Sharda Cropchem Ltd 793.05 -0.35 11.43 11438.15 754.66 1.89
Amines and Plasticizers Ltd 186.81 -1.30 26.65 6975.44 331.99 0.27
Indogulf Cropsciences Ltd 72.24 -0.30 11.84 6185.22 63.31 0.00

Company Info

The Company was initially formed as a partnership firm as "Anupam Rasayan" with effect from April 1, 1984 at Surat, Gujarat, India to commence the business of manufacture and sale of chemicals, pursuant to a partnership deed dated April 6, 1984 entered into amongst Ms. Hansa Sureshchandra Desai, Ms. Soniya Sureshchandra Desai, Ms. Purnima Ashwin Desai and Mr. Ashwin Jayantilal Desai. The partnership firm was registered under the Indian Partnership Act, 1932 with the Registrar of Firms, Surat on October 22, 1984. One of the Promoters, Mr. Anand S Desai was inducted as a partner with effect from April 1, 1992 in the firm pursuant to a partnership deed dated July 1, 1992. Further, one of the Promoters, Ms. Mona A Desai, along with Mr. Rohan Ashwin Desai and Mr. Aman Ashwin Desai were admitted as partners in the firm with effect from April 1, 2001, pursuant to a partnership deed dated March 18, 2002.Subsequently, pursuant to the memorandum of association dated September 5, 2003 and the certificate of incorporation issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli on September 30, 2003, the partnership firm was converted into a joint stock company and was registered as a public limited company under the Companies Act 1956 under the name of `Anupam Rasayan India Limited'. We received the certificate of commencement of business, issued by the Assistant Registrar of Companies, Gujarat, on November 20, 2003.Major events and milestones :1984- The Company was initially formed as a partnership firm as "Anupam Rasayan" to commence the business of manufacture and sale of chemicals2003- The partnership firm was converted into a joint stock company and was registered as a public limited company under the Companies Act 1956 under the name of `Anupam Rasayan India Limited'2010- Started supplying specialty chemicals to Syngenta Asia Pacific Pte Ltd in Singapore2014- Purchased the entire lease hold rights over the property and manufacturing facility at Plot No. 907/3, Jhagadia, Gujarat from Krishna Solvechem Limited pursuant to a Deed of Conveyance dated August 13, 2014 and an Asset Transfer Agreement dated May 16, 2014 respectively2015- Received consent to establish for setting up the industrial plant at Jhagadia Unit-5 from GPCB2016- KPI LLC made its first tranche of investment in the Company2017- Commenced the supply of speciality chemicals to Sumitomo Chemical Company Limited in Japan2018- KPI LLC invested USD 35 million as an external commercial borrowing in the Company2019- Received consolidated consents and authorisation for Jhagadia Unit - 5 and Sachin Unit-6, both from GPCB2020- Received consolidated consent and authorisation for the research and development centre on Sachin Unit-6 from GPCB 2022 -Anupam Rasayan India bags order worth $95 mil. from crop protection firm. 2025-The Company's BOD  has approved the acquisition of Monitchem Kansas SARL and its subsidiaries.-Anupam Rasayan inks long-term supply pact with Leading Japanese Multinational, expands presence in Japan.-Anupam Rasayan Signs LOI with US MNC, for supply of High-Performance Speciality Chemical Product.-Anupam Rasayan Signs Master Purchase Agreement with Japanese Multinational Conglomerate.

The Company was initially formed as a partnership firm as "Anupam Rasayan" with effect from April 1, 1984 at Surat, Gujarat, India to commence the business of manufacture and sale of chemicals, pursuant to a partnership deed dated April 6, 1984 entered into amongst Ms. Hansa Sureshchandra Desai, Ms. Soniya Sureshchandra Desai, Ms. Purnima Ashwin Desai and Mr. Ashwin Jayantilal Desai. The partnership firm was registered under the Indian Partnership Act, 1932 with the Registrar of Firms, Surat on October 22, 1984. One of the Promoters, Mr. Anand S Desai was inducted as a partner with effect from April 1, 1992 in the firm pursuant to a partnership deed dated July 1, 1992. Further, one of the Promoters, Ms. Mona A Desai, along with Mr. Rohan Ashwin Desai and Mr. Aman Ashwin Desai were admitted as partners in the firm with effect from April 1, 2001, pursuant to a partnership deed dated March 18, 2002.Subsequently, pursuant to the memorandum of association dated September 5, 2003 and the certificate of incorporation issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli on September 30, 2003, the partnership firm was converted into a joint stock company and was registered as a public limited company under the Companies Act 1956 under the name of `Anupam Rasayan India Limited'. We received the certificate of commencement of business, issued by the Assistant Registrar of Companies, Gujarat, on November 20, 2003.Major events and milestones :1984- The Company was initially formed as a partnership firm as "Anupam Rasayan" to commence the business of manufacture and sale of chemicals2003- The partnership firm was converted into a joint stock company and was registered as a public limited company under the Companies Act 1956 under the name of `Anupam Rasayan India Limited'2010- Started supplying specialty chemicals to Syngenta Asia Pacific Pte Ltd in Singapore2014- Purchased the entire lease hold rights over the property and manufacturing facility at Plot No. 907/3, Jhagadia, Gujarat from Krishna Solvechem Limited pursuant to a Deed of Conveyance dated August 13, 2014 and an Asset Transfer Agreement dated May 16, 2014 respectively2015- Received consent to establish for setting up the industrial plant at Jhagadia Unit-5 from GPCB2016- KPI LLC made its first tranche of investment in the Company2017- Commenced the supply of speciality chemicals to Sumitomo Chemical Company Limited in Japan2018- KPI LLC invested USD 35 million as an external commercial borrowing in the Company2019- Received consolidated consents and authorisation for Jhagadia Unit - 5 and Sachin Unit-6, both from GPCB2020- Received consolidated consent and authorisation for the research and development centre on Sachin Unit-6 from GPCB 2022 -Anupam Rasayan India bags order worth $95 mil. from crop protection firm. 2025-The Company's BOD  has approved the acquisition of Monitchem Kansas SARL and its subsidiaries.-Anupam Rasayan inks long-term supply pact with Leading Japanese Multinational, expands presence in Japan.-Anupam Rasayan Signs LOI with US MNC, for supply of High-Performance Speciality Chemical Product.-Anupam Rasayan Signs Master Purchase Agreement with Japanese Multinational Conglomerate.

Parent Organisation

Anupam Rasayan India Ltd.

Founded

30/09/2003

Managing Director

Mr.Anand Sureshbhai Desai

NSE Symbol

ANURASEQ

FAQ